Key result
Circulating hsa_circRNA_102893 levels effectively discriminated pregnant women with gestational diabetes mellitus from healthy controls, yielding an AUC of 0.806 in the training set.
Why the study?
Detecting gestational diabetes mellitus in early pregnancy remains challenging due to a poor availability of reliable biomarkers.
Does circulating hsa_circRNA_102893 accurately detect gestational diabetes mellitus in early pregnancy?
Case-Control (n=736)
No
Does circulating hsa_circRNA_102893 accurately detect gestational diabetes mellitus in early pregnancy?
Effect estimate: AUC 0.806 (95% CI 0.594-0.937)
p-value: p=0.0011
Hsa_circRNA_102893 is significantly downregulated in gestational diabetes mellitus and may serve as a novel noninvasive biomarker for its early detection.
May support hsa_circRNA_102893 evaluation as an early GDM biomarker; leaves open prospective validation before clinical adoption.
Due to a poor availability of reliable biomarkers, detecting gestational diabetes mellitus (GDM) in early pregnancy remains a challenge. Novel biomarkers like Circular RNAs (circRNAs) may be a promising diagnostic tool. The aim of this study was (a) to identify circRNAs deregulated in GDM and (b) evaluate the potential of circRNAs in detecting GDM. The circRNAs expression profiling in 6 paired women (with and without GDM) was measured by microarray. The levels of five most relevant circRNAs were validated in 12 paired participants by qRT-PCR. To verify the reproducibility of qRT-PCR, significantly differential expressed circRNA levels were confirmed in 18 paired participants. A receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value. The areas under ROC curves of hsa_circRNA_102893 were 0.806 (95% CI 0.594-0.937) and 0.741 (0.568-0.872) in training set and test set, respectively. Circulating circRNAs reflect the presence of GDM. Hsa_circRNA_102893 may be a potential novel and stable noninvasive biomarker for detecting GDM in early pregnancy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) conducted a case-control in Gestational diabetes mellitus (GDM) (n=736). hsa_circRNA_102893 expression vs. Healthy pregnant women (non-GDM) was evaluated on Diagnostic accuracy (Area Under the ROC Curve) for detecting GDM (AUC 0.806, 95% CI 0.594-0.937, p=0.0011). Circulating hsa_circRNA_102893 levels effectively discriminated pregnant women with gestational diabetes mellitus from healthy controls, yielding an AUC of 0.806 in the training set.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: